Area of research
Genetics · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Glioma Diagnosis and Treatment, Medical Imaging Techniques and Applications, Radiomics and Machine Learning in Medical Imaging, and Meningioma and schwannoma management.
Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
RANO criteria for response assessment of brain metastases based on amino acid PET imaging
Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomas
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0
Response Assessment in Neuro-Oncology (RANO) 2009–2025: Broad scope and implementation—A progress report
3D printing of radioactive wall-less PET phantoms improves threshold-based target delineation and quantification
Availability and use of PET in patients with brain tumours – a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey
Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningioma
Validation of SUV thresholds in [¹⁸F]SiTATE PET/CT for accurate meningioma segmentation
Retrospective Evaluation of the Correlation Between Somatostatin Receptor PET/CT and Histopathology in Patients with Suspected Intracranial Meningiomas
Tumor Asphericity in FDG PET Is an Independent Prognostic Parameter Improving Risk Stratification in Patients with Head and Neck Squamous Cell Carcinoma
Distinct reduction in relative microglial glucose uptake compared to astrocytes and neurons upon isolation from the brain environment
BIOM-58. HETEROGENEITY OF TSPO PET LABELLING ACROSS GLIOMA ENTITIES
Neuroinflammation detected by TSPO-PET precedes dopaminergic neuronal loss in mnt following BCMA-directed CAR-T therapy: Longitudinal multimodal neuroimaging and biomarker insights
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients
Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome
European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection
Associations between sex, body mass index and the individual microglial response in Alzheimer’s disease
Radioligand therapies in meningioma: Evidence and future directions
Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET
Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessments
FET PET-based target volume delineation for the radiotherapy of glioblastoma: A pictorial guide to help overcome methodological pitfalls
Remote Neuroinflammation in Newly Diagnosed Glioblastoma Correlates with Unfavorable Clinical Outcome
Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer’s disease
Flip-flop phenomenon on dual SSTR PET and amino acid PET in a case of recurrent meningioma with malignant transformation
Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06)
Patterns of intersectional tumor volumes in T2-weighted MRI and [18F]FET PET in adult glioma: a prospective, observational study